Related references
Note: Only part of the references are listed.Arachidonic acid release mediated by OX1 orexin receptors
Pauli M. Turunen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Involvement of TRPC3 channels in calcium oscillations mediated by OX1 orexin receptors
Hanna M. Peltonen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Enhanced orexin Receptor-2 Signaling Prevents Diet-Induced Obesity and Improves Leptin Sensitivity
Hiromasa Funato et al.
CELL METABOLISM (2009)
Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice
H. Tsuneki et al.
DIABETOLOGIA (2008)
Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway
Eva Goencz et al.
ENDOCRINOLOGY (2008)
Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion
Esther Van de Wall et al.
ENDOCRINOLOGY (2008)
The neurohormone orexin stimulates hypoxia-inducible factor-1 activity
Devanjan Sikder et al.
GENES & DEVELOPMENT (2007)
Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B
J. E. Digby et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions
J Hara et al.
NEUROSCIENCE LETTERS (2005)
Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity
JF Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat
M Ehrström et al.
REGULATORY PEPTIDES (2004)
Orexin-A expression in human peripheral tissues
M Nakabayashi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Expression of peroxisome proliferator-activated receptor-γ1 and peroxisome proliferator-activated receptor-γ2 in visceral and subcutaneous adipose tissue of obese women
V Giusti et al.
DIABETES (2003)
Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts
A Gray et al.
ANALYTICAL BIOCHEMISTRY (2003)
Glucose regulates the release of orexin-A from the endocrine pancreas
R Ouedraogo et al.
DIABETES (2003)
Reduction of blood glucose level by orexins in fasting normal and streptozotocin-diabetic mice
H Tsuneki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Orexins and adipoinsular axis function in the rat
MM Switonska et al.
REGULATORY PEPTIDES (2002)
Decreased plasma orexin-A levels in obese individuals
JA Adam et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Differential effects of phosphatidylinositol 3-kinase inhibition on intracellular signals regulating GLUT4 translocation and glucose transport
R Somwar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Potentiation of glucose uptake, in 3T3-L1 adipocytes by PPARγ agonists is maintained in cells expressing a PPARγ dominant-negative mutant:: Evidence for selectivity in the downstream responses to PPARγ activation
C Nugent et al.
MOLECULAR ENDOCRINOLOGY (2001)
Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy
S Nishino et al.
ANNALS OF NEUROLOGY (2001)
Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity
J Hara et al.
NEURON (2001)
Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity
J Berger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes
SG Tang et al.
DIABETES (2001)
Hypocretin (orexin) deficiency in human narcolepsy
S Nishino et al.
LANCET (2000)